Cargando…

Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora

This study investigated the effect of glucocorticoids combined with probiotics on inflammatory factors and intestinal microflora in the treatment of Crohn's disease. Eighty-three patients with Crohn's disease were selected from March 2015 to December 2017 in PLA Army General Hospital (Beij...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Hui, Kang, Qian, Wang, Haihong, Yin, Hui, Duan, Linghui, Liu, Yuli, Fan, Ruying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125941/
https://www.ncbi.nlm.nih.gov/pubmed/30214517
http://dx.doi.org/10.3892/etm.2018.6559
_version_ 1783353243276935168
author Su, Hui
Kang, Qian
Wang, Haihong
Yin, Hui
Duan, Linghui
Liu, Yuli
Fan, Ruying
author_facet Su, Hui
Kang, Qian
Wang, Haihong
Yin, Hui
Duan, Linghui
Liu, Yuli
Fan, Ruying
author_sort Su, Hui
collection PubMed
description This study investigated the effect of glucocorticoids combined with probiotics on inflammatory factors and intestinal microflora in the treatment of Crohn's disease. Eighty-three patients with Crohn's disease were selected from March 2015 to December 2017 in PLA Army General Hospital (Beijing, China). A total of 83 patients were randomly divided into the control group and treatment group. Patients in the control group were treated with routine treatment of oral sulfasalazine. Besides oral sulfasalazine, patients in the treatment group were treated with probiotics combined with glucocorticoids. At the same time, a total of 40 healthy individuals were selected to serve as the healthy group (received no treatment). Clinical efficacy, changes of inflammatory factors, incidence of infection and changes of intestinal flora were compared between the different groups. After treatment, the levels of inflammatory factors in both groups significantly decreased, and the reduction in the treatment group significantly increased than that in the control group (P<0.05). The levels of inflammatory cytokines in the treatment group reached the levels of that in the healthy individuals after treatment. After treatment, the levels of yeast, enterococci and peptococcus of the two groups of patients were significantly decreased, while the level of lactobacillus was significantly increased, and the changes were more significant in the treatment group than those in the control group. After treatment, the number of intestinal flora in the treatment group reached that of the healthy individuals. Treatment efficiency of the treatment group was significantly higher than that of the control group, and the infection rate of the control group was significantly higher than that of the treatment group (P<0.05). The use of probiotics combined with glucocorticoid in the treatment of Crohn's disease can improve clinical curative effect, reduce the secretion of inflammatory factors and improve the level of intestinal flora, so as to achieve better outcomes compared with conventional method.
format Online
Article
Text
id pubmed-6125941
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-61259412018-09-13 Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora Su, Hui Kang, Qian Wang, Haihong Yin, Hui Duan, Linghui Liu, Yuli Fan, Ruying Exp Ther Med Articles This study investigated the effect of glucocorticoids combined with probiotics on inflammatory factors and intestinal microflora in the treatment of Crohn's disease. Eighty-three patients with Crohn's disease were selected from March 2015 to December 2017 in PLA Army General Hospital (Beijing, China). A total of 83 patients were randomly divided into the control group and treatment group. Patients in the control group were treated with routine treatment of oral sulfasalazine. Besides oral sulfasalazine, patients in the treatment group were treated with probiotics combined with glucocorticoids. At the same time, a total of 40 healthy individuals were selected to serve as the healthy group (received no treatment). Clinical efficacy, changes of inflammatory factors, incidence of infection and changes of intestinal flora were compared between the different groups. After treatment, the levels of inflammatory factors in both groups significantly decreased, and the reduction in the treatment group significantly increased than that in the control group (P<0.05). The levels of inflammatory cytokines in the treatment group reached the levels of that in the healthy individuals after treatment. After treatment, the levels of yeast, enterococci and peptococcus of the two groups of patients were significantly decreased, while the level of lactobacillus was significantly increased, and the changes were more significant in the treatment group than those in the control group. After treatment, the number of intestinal flora in the treatment group reached that of the healthy individuals. Treatment efficiency of the treatment group was significantly higher than that of the control group, and the infection rate of the control group was significantly higher than that of the treatment group (P<0.05). The use of probiotics combined with glucocorticoid in the treatment of Crohn's disease can improve clinical curative effect, reduce the secretion of inflammatory factors and improve the level of intestinal flora, so as to achieve better outcomes compared with conventional method. D.A. Spandidos 2018-10 2018-08-02 /pmc/articles/PMC6125941/ /pubmed/30214517 http://dx.doi.org/10.3892/etm.2018.6559 Text en Copyright: © Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Su, Hui
Kang, Qian
Wang, Haihong
Yin, Hui
Duan, Linghui
Liu, Yuli
Fan, Ruying
Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora
title Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora
title_full Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora
title_fullStr Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora
title_full_unstemmed Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora
title_short Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora
title_sort effects of glucocorticoids combined with probiotics in treating crohn's disease on inflammatory factors and intestinal microflora
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125941/
https://www.ncbi.nlm.nih.gov/pubmed/30214517
http://dx.doi.org/10.3892/etm.2018.6559
work_keys_str_mv AT suhui effectsofglucocorticoidscombinedwithprobioticsintreatingcrohnsdiseaseoninflammatoryfactorsandintestinalmicroflora
AT kangqian effectsofglucocorticoidscombinedwithprobioticsintreatingcrohnsdiseaseoninflammatoryfactorsandintestinalmicroflora
AT wanghaihong effectsofglucocorticoidscombinedwithprobioticsintreatingcrohnsdiseaseoninflammatoryfactorsandintestinalmicroflora
AT yinhui effectsofglucocorticoidscombinedwithprobioticsintreatingcrohnsdiseaseoninflammatoryfactorsandintestinalmicroflora
AT duanlinghui effectsofglucocorticoidscombinedwithprobioticsintreatingcrohnsdiseaseoninflammatoryfactorsandintestinalmicroflora
AT liuyuli effectsofglucocorticoidscombinedwithprobioticsintreatingcrohnsdiseaseoninflammatoryfactorsandintestinalmicroflora
AT fanruying effectsofglucocorticoidscombinedwithprobioticsintreatingcrohnsdiseaseoninflammatoryfactorsandintestinalmicroflora